Table 4 Pairwise comparisons of well-being, service use and spending
From: Addressing the double-burden of diabetes and tuberculosis: lessons from Kyrgyzstan
Diabetes v co-affected | Tuberculosis v co-affected | Tuberculosis v diabetes | ||
|---|---|---|---|---|
Coefficient (95% CI) | Coefficient (95% CI) | Coefficient (95% CI) | ||
Well-being | ||||
SF-8 Physical component | −0.966 (−5.720 to 3.788) | 3.548 (−1.203 to 8.299) | 4.514 (1.602 to 7.425)*** | |
SF-8 Mental component | 6.254 (1.843 to 10.665)** | 3.982 (−0.426 to 8.390) | −2.272 (−4.973 to 0.430) | |
Probability of resource use | ||||
Any hospital visit | −0.177 (−0.361 to 0.006) | 0.048 (−0.135 to 0.231) | 0.225 (0.113 to 0.338)*** | |
Any ER/A&E visit | −0.067 (−0.205 to 0.071) | 0.012 (−0.127 to 0.150) | 0.079 (−0.006 to 0.163) | |
Hospital drug dispensary use | −0.044 (−0.250 to 0.162) | −0.467 (−0.673 to −0.261)*** | −0.423 (−0.549 to −0.297)*** | |
Any outpatient visit | 0.012 (−0.151 to 0.175) | −0.247 (−0.410 to −0.084)*** | −0.259 (−0.359 to −0.159)*** | |
Probability of spending on resource | ||||
Any spending | 0.200 (−0.026 to 0.427) | −0.020 (−0.247 to 0.206) | −0.220 (−0.359 to −0.082)** | |
Any drug spend | 0.176 (−0.049 to 0.401) | −0.044 (−0.269 to 0.181) | −0.220 (−0.357 to −0.082)** | |
Any hospital spending | −0.065 (−0.170 to 0.041) | −0.022 (−0.127 to 0.083) | 0.043 (−0.022 to 0.107) | |
Any outpatient spending | 0.196 (0.047 to 0.345)** | 0.079 (−0.070 to 0.228) | −0.112 (−0.207 to −0.025)** | |
Total monthly spending (K$) | ||||
All monthly spend | 269 (−236 to 774) | −189 (−694 to 316) | −458 (−768 to −149)** | |
Monthly drug spend | 56 (−165 to 277) | −182 (−403 to 39) | −238 (−374 to −103)*** | |
Monthly Hospital spending | 25 (−264 to 313) | −39 (−327 to 249) | −63 (−240 to 113) | |
Monthly outpatient spending | 188 (−131 to 507) | 31 (−288 to 350) | −157 (−352 to 39) | |
Catastrophic spending | ||||
Percent of monthly income | 10.62 (−10.56 to 31.81) | −6.50 (−27.73 to 14.74) | −17.12 (−30.47 to −3.77)** | |
Probability catastrophic | 0.121 (−0.060 to 0.303) | −0.113 (−0.295 to 0.069) | −0.234 (−0.349 to −0.120)*** | |